[Diagnosis and differential diagnosis of cervical adenocarcinoma].

Standard

[Diagnosis and differential diagnosis of cervical adenocarcinoma]. / Löning, Thomas; Riethdorf, L; Köbel, M.

in: PATHOLOGE, Jahrgang 32, Nr. 6, 6, 2011, S. 505-513.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Löning T, Riethdorf L, Köbel M. [Diagnosis and differential diagnosis of cervical adenocarcinoma]. PATHOLOGE. 2011;32(6):505-513. 6.

Bibtex

@article{d311f9a6c7fe4503927227a3143938da,
title = "[Diagnosis and differential diagnosis of cervical adenocarcinoma].",
abstract = "This overview summarizes pathogenetic and practical aspects of (sub-)classification of cervical glandular (pre-)neoplasias and, inter alia, calls into question the usefulness of grading. In the context of the differential diagnosis of benign {"}imitations{"}, the phenotypic variability of glandular precancerous lesions and carcinomas is described as well as the use of special tests to distinguish them. With regard to carcinomas, the differential diagnosis of well-differentiated neoplasias is addressed including {"}minimal deviation{"} adenocarcinoma (MDA, malignant adenoma), carcinomas with endometrioid or villoglandular morphology, and mesonephric hyper- and neoplasias. Furthermore, knowledge of HPV-negative glandular (pre-)neoplasias is covered including {"}gastric-type{"} adenocarcinomas and diagnostic algorithms for discriminating between primary and secondary cervical adenocarcinomas. Finally, comments are offered on the difficulties in recognizing early invasive adenocarcinomas, especially also the pitfalls inherent in determining the depth of invasion.",
keywords = "Diagnosis, Differential, Humans, Female, Algorithms, Neoplasm Invasiveness, Tumor Markers, Biological/analysis, Ki-67 Antigen/analysis, Cell Transformation, Neoplastic/pathology, Cervix Uteri/pathology, Adenocarcinoma/classification/diagnosis/*pathology, Human papillomavirus 16, Papillomavirus Infections/classification/diagnosis/pathology, Precancerous Conditions/classification/diagnosis/pathology, Proto-Oncogene Proteins c-bcl-2/analysis, Tumor Suppressor Protein p53/analysis, Ubiquitin-Protein Ligases/analysis, Uterine Cervical Neoplasms/classification/diagnosis/*pathology, Diagnosis, Differential, Humans, Female, Algorithms, Neoplasm Invasiveness, Tumor Markers, Biological/analysis, Ki-67 Antigen/analysis, Cell Transformation, Neoplastic/pathology, Cervix Uteri/pathology, Adenocarcinoma/classification/diagnosis/*pathology, Human papillomavirus 16, Papillomavirus Infections/classification/diagnosis/pathology, Precancerous Conditions/classification/diagnosis/pathology, Proto-Oncogene Proteins c-bcl-2/analysis, Tumor Suppressor Protein p53/analysis, Ubiquitin-Protein Ligases/analysis, Uterine Cervical Neoplasms/classification/diagnosis/*pathology",
author = "Thomas L{\"o}ning and L Riethdorf and M K{\"o}bel",
year = "2011",
language = "Deutsch",
volume = "32",
pages = "505--513",
journal = "PATHOLOGE",
issn = "0172-8113",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - [Diagnosis and differential diagnosis of cervical adenocarcinoma].

AU - Löning, Thomas

AU - Riethdorf, L

AU - Köbel, M

PY - 2011

Y1 - 2011

N2 - This overview summarizes pathogenetic and practical aspects of (sub-)classification of cervical glandular (pre-)neoplasias and, inter alia, calls into question the usefulness of grading. In the context of the differential diagnosis of benign "imitations", the phenotypic variability of glandular precancerous lesions and carcinomas is described as well as the use of special tests to distinguish them. With regard to carcinomas, the differential diagnosis of well-differentiated neoplasias is addressed including "minimal deviation" adenocarcinoma (MDA, malignant adenoma), carcinomas with endometrioid or villoglandular morphology, and mesonephric hyper- and neoplasias. Furthermore, knowledge of HPV-negative glandular (pre-)neoplasias is covered including "gastric-type" adenocarcinomas and diagnostic algorithms for discriminating between primary and secondary cervical adenocarcinomas. Finally, comments are offered on the difficulties in recognizing early invasive adenocarcinomas, especially also the pitfalls inherent in determining the depth of invasion.

AB - This overview summarizes pathogenetic and practical aspects of (sub-)classification of cervical glandular (pre-)neoplasias and, inter alia, calls into question the usefulness of grading. In the context of the differential diagnosis of benign "imitations", the phenotypic variability of glandular precancerous lesions and carcinomas is described as well as the use of special tests to distinguish them. With regard to carcinomas, the differential diagnosis of well-differentiated neoplasias is addressed including "minimal deviation" adenocarcinoma (MDA, malignant adenoma), carcinomas with endometrioid or villoglandular morphology, and mesonephric hyper- and neoplasias. Furthermore, knowledge of HPV-negative glandular (pre-)neoplasias is covered including "gastric-type" adenocarcinomas and diagnostic algorithms for discriminating between primary and secondary cervical adenocarcinomas. Finally, comments are offered on the difficulties in recognizing early invasive adenocarcinomas, especially also the pitfalls inherent in determining the depth of invasion.

KW - Diagnosis, Differential

KW - Humans

KW - Female

KW - Algorithms

KW - Neoplasm Invasiveness

KW - Tumor Markers, Biological/analysis

KW - Ki-67 Antigen/analysis

KW - Cell Transformation, Neoplastic/pathology

KW - Cervix Uteri/pathology

KW - Adenocarcinoma/classification/diagnosis/pathology

KW - Human papillomavirus 16

KW - Papillomavirus Infections/classification/diagnosis/pathology

KW - Precancerous Conditions/classification/diagnosis/pathology

KW - Proto-Oncogene Proteins c-bcl-2/analysis

KW - Tumor Suppressor Protein p53/analysis

KW - Ubiquitin-Protein Ligases/analysis

KW - Uterine Cervical Neoplasms/classification/diagnosis/pathology

KW - Diagnosis, Differential

KW - Humans

KW - Female

KW - Algorithms

KW - Neoplasm Invasiveness

KW - Tumor Markers, Biological/analysis

KW - Ki-67 Antigen/analysis

KW - Cell Transformation, Neoplastic/pathology

KW - Cervix Uteri/pathology

KW - Adenocarcinoma/classification/diagnosis/pathology

KW - Human papillomavirus 16

KW - Papillomavirus Infections/classification/diagnosis/pathology

KW - Precancerous Conditions/classification/diagnosis/pathology

KW - Proto-Oncogene Proteins c-bcl-2/analysis

KW - Tumor Suppressor Protein p53/analysis

KW - Ubiquitin-Protein Ligases/analysis

KW - Uterine Cervical Neoplasms/classification/diagnosis/pathology

M3 - SCORING: Zeitschriftenaufsatz

VL - 32

SP - 505

EP - 513

JO - PATHOLOGE

JF - PATHOLOGE

SN - 0172-8113

IS - 6

M1 - 6

ER -